Penelope Markham Biovie Inc. (BIVI) insider trading activity

BIVI Quotes by TradingView

Penelope Markham is EVP Liver Cirrhosis R&D of BIOVIE INC.. Currently has a direct ownership of 47,841 shares of BIVI, which is worth approximately $108,599. The most recent transaction as insider was on Feb 16, 2023, when has been sold 2,476 shares (Common Stock) at a price of $6.12 per share, resulting in proceeds of $15,153. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.8K
0% 3M change
0% 12M change
Total Value Held $108,599

PENELOPE MARKHAM Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 16 2023
SELL
Payment of exercise price or tax liability
$15,153 $6.12 p/Share
2,476 Reduced 4.92%
47,841 Common Stock
Nov 23 2022
BUY
Grant, award, or other acquisition
-
39,624 Added 44.06%
50,317 Common Stock
PM

Penelope Markham

EVP Liver Cirrhosis R&D
Santa Monica, CA

Track Institutional and Insider Activities on BIVI

Follow BIOVIE INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIVI shares.

Notify only if

Insider Trading

Get notified when an Biovie Inc. insider buys or sells BIVI shares.

Notify only if

News

Receive news related to BIOVIE INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BIVI